Company Overview
Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache. It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler. In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services. It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.
Why Investors Should Care
Revenue has grown at a 22.1% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.13.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $70.58M (+22.3% YoY); net profit $-34.75M.
- Trailing 12 Months Year-on-year growth — revenue +46.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 22.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 22.05% |
| 1 Year: | 46.20% |
Stock Price Performance
| 1 Year: | +88.34% |
| 6 Months: | -28.67% |
| 3 Months: | -37.03% |
| 1 Month: | -21.21% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Arteris licenses network-on-chip (NoC) interconnect IP that is essential to designing the complex system-on-chips powering AI, automotive and edge devices.
On-chip interconnect IP (FlexNoC, Ncore) that connects the many processing blocks inside AI and high-performance SoCs.
- NoC IP for AI SoCs Arteris's interconnect IP manages communication between CPUs, GPUs, NPUs and memory in complex AI chips and chiplets.
- Chiplet & multi-die support Its IP supports the chiplet architectures increasingly used in advanced AI silicon.
- Automotive & edge AI design wins Growing adoption in automotive and edge-AI SoCs expands its royalty base.
- Capital-light IP-licensing model levered directly to AI/edge chip design activity.
- Strong revenue growth (~39%) and very high gross margins (~89%).
- Still loss-making with negative returns — scaling toward profitability.
- Customer concentration and design-win timing make results lumpy.
Curated from public filings and analyst commentary; figures are illustrative.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 22.1% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 60.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AIP Arteris, Inc. R2KR3KTECHAI | 19.06 | -21.91 | $936.84M | 0.00% | -79.22% | -131.41% | 22.05% | - |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 210.96 | 26.64 | $5.09T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 347.72 | 39.88 | $5.07T | 0.32% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 524.51 | 29.19 | $3.89T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 418.51 | 31.19 | $2.17T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 321.68 | 41.08 | $1.54T | 0.72% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 877.55 | 19.82 | $991.10B | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 516.79 | 131.83 | $843.65B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,571.80 | 51.02 | $603.73B | 0.50% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.43M | 6.66M | 10.81M | 8.96M | 11.76M | 14.82M | 12.60M | 13.15M | 14.73M | 13.27M | 12.95M | 14.57M | 14.71M | 16.53M | 16.50M | 17.41M | 20.14M | 22.94M | 24.13M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.53M | 1.74M | 1.77M | 1.86M | 3.25M | - |
| Gross Profit | 6.20M | 5.79M | 9.95M | 8.08M | 10.78M | 13.53M | 11.67M | 12.03M | 13.51M | 11.99M | 11.48M | 13.12M | 13.25M | 15.01M | 14.76M | 15.64M | 18.28M | 19.69M | 20.53M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.71M | 23.01M | 24.36M | 26.74M | 28.40M | - |
| Operating Income | -2.62M | -6.45M | -3.52M | -4.52M | -6.62M | -5.43M | -7.75M | -8.76M | -8.68M | -8.45M | -9.13M | -7.44M | -7.92M | -7.71M | -8.25M | -8.71M | -8.47M | -8.72M | -13.91M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.15M | -6.62M | -7.24M | -6.89M | -7.28M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 48.00K | 42.00K | 49.00K | 54.00K | 38.00K | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.04M | -7.50M | -8.13M | -7.79M | -8.67M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 268.00K | 846.00K | 380.00K | -19.00K | -3.70M | - |
| Net Income | -3.84M | -6.72M | -3.91M | -4.97M | -6.82M | -5.67M | -7.68M | -9.01M | -9.16M | -8.15M | -9.40M | -8.34M | -7.69M | -8.12M | -9.13M | -8.99M | -8.50M | -7.96M | -14.06M |
| Diluted EPS | -0.22 | -0.36 | -0.20 | -0.24 | -0.22 | -0.18 | -0.23 | -0.26 | -0.26 | -0.23 | -0.25 | -0.22 | -0.20 | -0.20 | -0.22 | -0.21 | -0.19 | -0.17 | -0.30 |
| R&D Expense | 4.01M | 6.54M | 6.42M | 7.61M | 9.46M | 10.37M | 11.02M | 11.38M | 12.09M | 11.00M | 10.84M | 10.72M | 11.92M | 11.86M | 12.17M | 12.65M | - | 14.46M | 16.76M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 31.81M | - | 50.38M | 53.67M | 57.72M | 70.58M |
| Cost of Revenue | - | - | 4.28M | 5.08M | 5.96M | 6.89M |
| Gross Profit | 30.32M | - | 46.10M | 48.59M | 51.76M | 63.68M |
| Operating Expenses | - | - | 74.95M | 83.73M | 83.36M | 96.82M |
| Operating Income | -3.78M | - | -28.86M | -35.14M | -31.60M | -33.14M |
| EBITDA | - | - | -25.33M | -28.52M | -24.83M | -26.89M |
| Interest Expense | - | - | 89.00K | 211.00K | 244.00K | 193.00K |
| Pretax Income | - | - | -27.52M | -31.80M | -28.44M | -30.46M |
| Tax Provision | - | - | -417.00K | 1.68M | 2.50M | 1.48M |
| Net Income | -3.26M | - | -27.39M | -36.87M | -33.64M | -34.75M |
| Diluted EPS | -0.19 | - | -0.84 | -1.03 | -0.86 | -0.82 |
| R&D Expense | 17.02M | 30.81M | 41.17M | 45.13M | 45.01M | 49.91M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 42.74M | - | 115.52M | 102.80M | 106.14M | 115.03M |
| Current Assets | - | - | - | 81.11M | 58.43M | 69.08M | 82.39M |
| Cash & Equivalents | - | 11.74M | - | 37.42M | 13.70M | 13.68M | 33.90M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 6.63M | 11.06M | 19.37M | 17.49M |
| Total Liabilities | - | 49.03M | - | 77.98M | 87.70M | 107.32M | 129.66M |
| Current Liabilities | - | 28.23M | - | 43.67M | 46.40M | 59.28M | 73.20M |
| Long Term Debt | - | - | - | 448.00K | 1.29M | 594.00K | 452.00K |
| Total Debt | - | - | - | 3.62M | 7.75M | 5.99M | 5.97M |
| Total Equity | -9.43M | -12.01M | - | 37.53M | 15.10M | -1.19M | -14.63M |
| Shares Outstanding | - | - | - | 34.63M | 37.52M | 40.72M | 44.27M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.16M | - | -6.77M | -15.73M | -720.00K | 6.73M |
| Investing Cash Flow | -5.15M | - | -37.48M | -4.69M | 970.00K | 12.03M |
| Financing Cash Flow | 790.00K | - | -4.15M | -2.92M | -262.00K | 1.42M |
| Capital Expenditure | -654.00K | - | -1.05M | -1.50M | -324.00K | -1.39M |
| Free Cash Flow | 1.51M | - | -7.82M | -17.23M | -1.04M | 5.34M |
| Net Change in Cash | - | - | -48.40M | -23.34M | -12.00K | 20.18M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 95.3% | - | 91.5% | 90.5% | 89.7% | 90.2% |
| Operating Margin % | -11.9% | - | -57.3% | -65.5% | -54.7% | -47.0% |
| Net Margin % | -10.2% | - | -54.4% | -68.7% | -58.3% | -49.2% |
| ROE % | 27.1% | - | -73.0% | -244.1% | 2,831.5% | 237.5% |
| ROCE % | -26.0% | - | -40.2% | -62.3% | -67.4% | -79.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Needham Investment Management, L.L.C. | 7.99% | 3.93M | $88.13M |
| 2 | Blackrock Inc. | 6.70% | 3.30M | $73.95M |
| 3 | Vanguard Capital Management LLC | 3.08% | 1.51M | $33.97M |
| 4 | Franklin Resources, Inc. | 3.05% | 1.50M | $33.64M |
| 5 | Federated Hermes, Inc. | 2.87% | 1.41M | $31.68M |
| 6 | Acadian Asset Management. LLC | 2.55% | 1.25M | $28.10M |
| 7 | Nuveen, LLC | 2.17% | 1.07M | $23.90M |
| 8 | Goldman Sachs Group Inc | 2.05% | 1.01M | $22.62M |
| 9 | Jacobs Levy Equity Management, Inc. | 2.00% | 981.79K | $22.03M |
| 10 | Geode Capital Management, LLC | 1.80% | 885.75K | $19.88M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AIP
Arteris (AIP) Stock Fair Value Falls As Analysts Weigh Chiplet Growth Potential
Arteris is under fresh scrutiny after one widely followed fair value estimate shifted from about US$41.00 to roughly US$37.29, signaling a more tempered price target narrative. Recent research highlights growing interest in Arteris system I…
Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026
CAMPBELL, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced it will release its financial results for the third q…
Arteris (AIP) Following Security Program Expansion Is The Undervalued Narrative Back
Why Arteris Is Back On Investor Radars Arteris (AIP) is drawing fresh attention after expanding its third party IP security assurance program with BAE Systems and SiFive, supported by an additional US$3.3 million from a US defense microelec…
Is Arteris (AIP) Getting Too Pricey For Its Sales?
Arteris has seen its share price move sharply in recent years, and after a pullback in recent weeks the key issue is whether the current US$20.41 level can be supported by the revenue the business is generating. With the focus firmly on chi…
Is Arteris (AIP) Using FlexGen Multi-Die to Quietly Reshape Its AI Chiplet Investment Story?
Earlier this year, Arteris, Inc. expanded its multi-die portfolio with the FlexGen Multi-Die product, designed to help semiconductor companies move from monolithic system-on-chip designs to chiplet-based architectures for AI, high-performan…
Arteris Accelerates Industry Transition to Multi-Die Chiplet-Based Architecture
Expanded solution includes new FlexGen Multi-Die product to address the challenge of efficient data movement for an industry that is shifting to multi-die architectures, while preserving quality of service and architectural flexibility acro…
AIP — Frequently Asked Questions
What is the current share price of Arteris, Inc. (AIP)?
As of 2026-10-23 16:27 PDT, Arteris, Inc. (AIP) trades at $19.06 on NasdaqGM. Its 52-week range is $8.59 to $48.59.
What is the market capitalisation of AIP?
Arteris, Inc. (AIP) has a market capitalisation of $936.84M on NasdaqGM.
What is the P/E ratio of AIP?
AIP trades at a trailing price-to-earnings (P/E) ratio of -21.91. The industry average P/E is 30.29. Its price-to-book (P/B) ratio is 16.26.
What is the return on equity (ROE) of AIP?
AIP has a return on equity (ROE) of -131.41%. Its return on capital employed (ROCE) is -79.22%.
Is AIP a good stock to buy?
This page provides a data-driven analysis of Arteris, Inc. (AIP), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.